| ACRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ACRX shares outstanding history going back to 2/4/2011:
Also see: ACRX Market Cap History ACRX YTD Return |
ACRX Shares Outstanding History — AcelRx Pharmaceuticals Share Count Over Time
As of 11/3/2023 AcelRx Pharmaceuticals has 16.95 million ACRX shares outstanding. Investors often track the ACRX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ACRX share count trends over time, with 54 historical shares outstanding datapoints presented, dating back to 2/4/2011.
| ACRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACRX Historical Shares Outstanding: +26.98% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ACRX Stock Price Chart |
| About Talphera Inc |
| AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Co.'s portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. Co.'s nafamostat product candidates include Niyad™, which is being developed as a regional anticoagulant for injection into the extracorporeal circuit; and LTX-608, which is Co.'s proprietary nafamostat formulation for direct IV infusion. Co.'s pre-filled syringe product candidates include Fedsyra™, which is an ephedrine pre-filled syringe; and the phenylephrine pre-filled syringe. We show 54 historical shares outstanding datapoints in our coverage of ACRX's shares outstanding history. Understanding the changing numbers of ACRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ACRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ACRX by allowing them to research ACRX shares outstanding history as well as any other stock in our coverage universe. |
| ACRX Current Stock Quote |
Quotes delayed 20 minutes  Free ACRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ACRX Share Performance |
| Shares Outstanding Peers |
| AcelRx Pharmaceuticals (ACRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ACST Shares Outstanding History ACTU Shares Outstanding History ACXP Shares Outstanding History ADGI Shares Outstanding History ADIL Shares Outstanding History ADMA Shares Outstanding History ADMP Shares Outstanding History ADMS Shares Outstanding History ADPT Shares Outstanding History ADRO Shares Outstanding History More Healthcare companies » |
ACRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
